Daphne Quimi
2012
In 2012, Daphne Quimi earned a total compensation of $325.4K as Controller and Former Principal Financial Officer at Amicus Therapeutics, a 6% decrease compared to previous year.
Compensation breakdown
| Bonus | $39,889 |
|---|---|
| Option Awards | $64,418 |
| Salary | $207,508 |
| Other | $13,584 |
| Total | $325,399 |
Quimi received $207.5K in salary, accounting for 64% of the total pay in 2012.
Quimi also received $39.9K in bonus, $64.4K in option awards and $13.6K in other compensation.
Rankings
In 2012, Daphne Quimi's compensation ranked 9,948th out of 11,487 executives tracked by ExecPay. In other words, Quimi earned more than 13.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,948 out of 11,487 | 13th |
Division Manufacturing | 3,691 out of 4,253 | 13th |
Major group Chemicals And Allied Products | 1,029 out of 1,198 | 14th |
Industry group Drugs | 782 out of 920 | 15th |
Industry Pharmaceutical Preparations | 597 out of 700 | 15th |
Source: SEC filing on April 26, 2013.
Quimi's colleagues
We found five more compensation records of executives who worked with Daphne Quimi at Amicus Therapeutics in 2012.
2012
John Crowley
Amicus Therapeutics
Chief Executive Officer
2012
David Lockhart
Amicus Therapeutics
Chief Scientific Officer
2012
William Baird
Amicus Therapeutics
Chief Financial Officer
2012
Bradley Campbell
Amicus Therapeutics
Chief Operating Officer
2012
Pol Boudes
Amicus Therapeutics